| 4IH5: reference: De novo fragment design: a medicinal chemistry approach to fragment-based lead generation., Talamas FX, Ao-Ieong G, Brameld KA, Chin E, de Vicente J, Dunn JP, Ghate M, Giannetti AM, Harris SF, Labadie SS, Leveque V, Li J, Lui AS, McCaleb KL, Najera I, Schoenfeld RC, Wang B, Wong A, J Med Chem. 2013 Apr 11;56(7):3115-9. doi: 10.1021/jm4002605. Epub 2013 Mar 29. PMID: 23509929 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).